Literature DB >> 16305901

Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery.

Munir Boodhwani1, William E Cohn, Jun Feng, Basel Ramlawi, Shigetoshi Mieno, Alexander Schwarz, Frank W Sellke.   

Abstract

PURPOSE: Coronary occlusion techniques used during off-pump coronary artery bypass surgery often provide suboptimal visualization and can damage the endothelium. We evaluated a novel gel with reverse thermosensitive properties for internal vessel occlusion during off-pump coronary artery bypass surgery. DESCRIPTION: Yorkshire pigs (n = 6 per group) underwent two cycles of mid-left anterior descending coronary artery (LAD) occlusion using the gel (injected into the artery) or microvascular clamps (control group) followed by 30 minutes of reperfusion. Regional wall motion and LAD flow were monitored, microvessel relaxation responses were evaluated, and myocardial tissue was analyzed histologically. EVALUATION: Complete left anterior descending coronary artery occlusion was successfully achieved using the gel (median ischemic time, 14 minutes; range, 4.5 to 24 minutes). Anterior wall motion abnormalities as well as flow patterns in the reperfused left anterior descending coronary artery were similar in both groups. Microvessel relaxation to substance P was mildly impaired (-11.7 +/- 2.8% vs control; p < 0.001) in the left anterior descending coronary artery territory, but response to adenosine diphosphate and sodium nitroprusside was unaffected. Mild contraction band necrosis was present in both groups, consistent with mild ischemia-reperfusion injury.
CONCLUSIONS: The gel represents a safe and effective method of vessel occlusion with a potentially important role in off-pump coronary artery bypass surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305901     DOI: 10.1016/j.athoracsur.2005.05.031

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Feasibility of bloodless liver resection using Lumagel, a reverse thermoplastic polymer, to produce temporary, targeted hepatic blood flow interruption.

Authors:  James J Pomposelli; Mohamed Akoad; Sebastian Flacke; James J Benn; Mauricio Solano; Aarti Kalra; Peter N Madras
Journal:  HPB (Oxford)       Date:  2011-11-21       Impact factor: 3.647

2.  LeGoo polymer injection into hydatid cyst would eliminate intraoperative spillage of scolices.

Authors:  Fadhil Al-Amran; Hayder M Abdulnabi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-16

3.  Temporary targeted hemostasis to facilitate bloodless partial nephrectomy.

Authors:  Niall J Harty; Alireza Moinzadeh; Sebastian Flacke; Jeffrey Pettit; James A Benn; John A Libertino; Peter N Madras
Journal:  Urology       Date:  2011-12       Impact factor: 2.649

4.  Endovascular temporary vessel occlusion with a reverse-thermosensitive polymer for bloodless minimally invasive renal surgery.

Authors:  Sebastian Flacke; Alirezah Moinzadeh; John A Libertino; John Merhige; Jean-Marie Vogel; Kathy Lyall; Urmila Khettry; Curtis W Bakal; Peter N Madras
Journal:  J Vasc Interv Radiol       Date:  2010-03-21       Impact factor: 3.464

5.  Endoscopic ultrasound-guided celiac plexus neurolysis using a reverse phase polymer.

Authors:  Keith L Obstein; Fernanda P Martins; Gloria Fernández-Esparrach; Christopher C Thompson
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

6.  Temporary vascular occlusion by rapid reverse phase polymer: a preliminary in vitro study of retrograde injection.

Authors:  Einar Dregelid
Journal:  Int J Biomater       Date:  2012-07-25

7.  Effects of temporary vascular occluder poloxamer 407 gel on the endothelium.

Authors:  Arif Gucu; Ilkin Cavusoglu; Onder Bozkurt; Cuneyt Eris; Faruk Toktas; Tugrul Goncu; Ahmet Ozyazicioglu
Journal:  J Cardiothorac Surg       Date:  2013-01-22       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.